These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 30190158)
1. Targeted therapy of pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018. Hoeper MM; Apitz C; Grünig E; Halank M; Ewert R; Kaemmerer H; Kabitz HJ; Kähler C; Klose H; Leuchte H; Ulrich S; Olsson KM; Distler O; Rosenkranz S; Ghofrani HA Int J Cardiol; 2018 Dec; 272S():37-45. PubMed ID: 30190158 [TBL] [Abstract][Full Text] [Related]
2. Risk stratification strategy and assessment of disease progression in patients with pulmonary arterial hypertension: Updated Recommendations from the Cologne Consensus Conference 2018. Leuchte HH; Ten Freyhaus H; Gall H; Halank M; Hoeper MM; Kaemmerer H; Kähler C; Riemekasten G; Ulrich S; Schwaiblmair M; Ewert R Int J Cardiol; 2018 Dec; 272S():20-29. PubMed ID: 30266353 [TBL] [Abstract][Full Text] [Related]
3. Pulmonary hypertension associated with left heart disease: Updated Recommendations of the Cologne Consensus Conference 2018. Rosenkranz S; Lang IM; Blindt R; Bonderman D; Bruch L; Diller GP; Felgendreher R; Gerges C; Hohenforst-Schmidt W; Holt S; Jung C; Kindermann I; Kramer T; Kübler WM; Mitrovic V; Riedel A; Rieth A; Schmeisser A; Wachter R; Weil J; Opitz CF Int J Cardiol; 2018 Dec; 272S():53-62. PubMed ID: 30527996 [TBL] [Abstract][Full Text] [Related]
4. General measures and supportive therapy for pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018. Grünig E; Benjamin N; Krüger U; Kaemmerer H; Harutyunova S; Olsson KM; Ulrich S; Gerhardt F; Neurohr C; Sablotzki A; Halank M; Marra AM; Kabitz HJ; Thimm G; Fliegel KG; Klose H Int J Cardiol; 2018 Dec; 272S():30-36. PubMed ID: 30190156 [TBL] [Abstract][Full Text] [Related]
5. Pulmonary hypertension due to lung diseases: Updated recommendations from the Cologne Consensus Conference 2018. Olschewski H; Behr J; Bremer H; Claussen M; Douschan P; Halank M; Held M; Hoeper MM; Holt S; Klose H; Krüger S; Lange TJ; Reichenberger F; Skowasch D; Ulrich S; Wilkens H; Seeger W Int J Cardiol; 2018 Dec; 272S():63-68. PubMed ID: 30131231 [TBL] [Abstract][Full Text] [Related]
6. Pulmonary hypertension in adults with congenital heart disease: Updated recommendations from the Cologne Consensus Conference 2018. Kaemmerer H; Apitz C; Brockmeier K; Eicken A; Gorenflo M; Hager A; de Haan F; Huntgeburth M; Kozlik-Feldmann RG; Miera O; Diller GP Int J Cardiol; 2018 Dec; 272S():79-88. PubMed ID: 30195841 [TBL] [Abstract][Full Text] [Related]
8. Pulmonary hypertension due to left heart disease: updated Recommendations of the Cologne Consensus Conference 2011. Rosenkranz S; Bonderman D; Buerke M; Felgendreher R; ten Freyhaus H; Grünig E; de Haan F; Hammerstingl C; Harreuter A; Hohenforst-Schmidt W; Kindermann I; Kindermann M; Kleber FX; Kuckeland M; Kuebler WM; Mertens D; Mitrovic V; Opitz C; Schmeisser A; Schulz U; Speich R; Zeh W; Weil J Int J Cardiol; 2011 Dec; 154 Suppl 1():S34-44. PubMed ID: 22221972 [TBL] [Abstract][Full Text] [Related]
9. Decompensated right heart failure, intensive care and perioperative management in patients with pulmonary hypertension: Updated recommendations from the Cologne Consensus Conference 2018. Olsson KM; Halank M; Egenlauf B; Fistera D; Gall H; Kaehler C; Kortmann K; Kramm T; Lichtblau M; Marra AM; Nagel C; Sablotzki A; Seyfarth HJ; Schranz D; Ulrich S; Hoeper MM; Lange TJ Int J Cardiol; 2018 Dec; 272S():46-52. PubMed ID: 30190155 [TBL] [Abstract][Full Text] [Related]
10. Pulmonary hypertension due to chronic lung disease: updated Recommendations of the Cologne Consensus Conference 2011. Hoeper MM; Andreas S; Bastian A; Claussen M; Ghofrani HA; Gorenflo M; Grohé C; Günther A; Halank M; Hammerl P; Held M; Krüger S; Lange TJ; Reichenberger F; Sablotzki A; Staehler G; Stark W; Wirtz H; Witt C; Behr J Int J Cardiol; 2011 Dec; 154 Suppl 1():S45-53. PubMed ID: 22221973 [TBL] [Abstract][Full Text] [Related]
11. Refined risk stratification, current treatment, and new therapeutic approaches in pulmonary arterial hypertension. Lange TJ Herz; 2023 Aug; 48(4):259-265. PubMed ID: 37085727 [TBL] [Abstract][Full Text] [Related]
12. [Pulmonary hypertension due to chronic lung disease. Recommendations of the Cologne Consensus Conference 2010]. Hoeper MM; Andreas S; Bastian A; Claussen M; Ghofrani HA; Gorenflo M; Grohé C; Günther A; Halank M; Hammerl P; Held M; Krüger S; Lange TJ; Reichenberger F; Sablotzki A; Staehler G; Stark W; Wirtz H; Witt C; Behr J Pneumologie; 2011 Apr; 65(4):208-18. PubMed ID: 21181642 [TBL] [Abstract][Full Text] [Related]
13. [Pulmonary hypertension due to chronic lung disease: Recommendations of the Cologne Consensus Conference 2016]. Olschewski H; Behr J; Bremer H; Claussen M; Douschan P; Halank M; Held M; Hoeper MM; Holt S; Klose H; Krüger S; Lange TJ; Reichenberger F; Skowasch D; Ulrich S; Wilkens H; Seeger W Dtsch Med Wochenschr; 2016 Oct; 141(S 01):S57-S61. PubMed ID: 27760451 [TBL] [Abstract][Full Text] [Related]
14. Management of Pulmonary Arterial Hypertension. Weatherald J; Varughese RA; Liu J; Humbert M Semin Respir Crit Care Med; 2023 Dec; 44(6):746-761. PubMed ID: 37369218 [TBL] [Abstract][Full Text] [Related]
15. Treatment of pulmonary arterial hypertension (PAH): updated Recommendations of the Cologne Consensus Conference 2011. Ghofrani HA; Distler O; Gerhardt F; Gorenflo M; Grünig E; Haefeli WE; Held M; Hoeper MM; Kähler CM; Kaemmerer H; Klose H; Köllner V; Kopp B; Mebus S; Meyer A; Miera O; Pittrow D; Riemekasten G; Rosenkranz S; Schranz D; Voswinckel R; Olschewski H Int J Cardiol; 2011 Dec; 154 Suppl 1():S20-33. PubMed ID: 22221970 [TBL] [Abstract][Full Text] [Related]
16. [Targeted therapy for pulmonary arterial hypertension in patients without comorbidities]. Klose H; Harbaum L; Richter MJ; Lichtblau M; Marra AM; Kabitz HJ; Harutyunova S; Milger-Kneidinger K; Lange TJ Pneumologie; 2023 Nov; 77(11):890-900. PubMed ID: 37963478 [TBL] [Abstract][Full Text] [Related]
17. Rationale and study design of RESPITE: An open-label, phase 3b study of riociguat in patients with pulmonary arterial hypertension who demonstrate an insufficient response to treatment with phosphodiesterase-5 inhibitors. Hoeper MM; Klinger JR; Benza RL; Simonneau G; Langleben D; Naeije R; Corris PA Respir Med; 2017 Jan; 122 Suppl 1():S18-S22. PubMed ID: 27887774 [TBL] [Abstract][Full Text] [Related]
18. [Targeted therapy of pulmonary arterial hypertension: Recommendations of the Cologne Consensus Conference 2016]. Hoeper MM; Apitz C; Grünig E; Halank M; Ewert R; Kaemmerer H; Kabitz HJ; Kähler C; Klose H; Leuchte H; Ulrich S; Olsson KM; Distler O; Rosenkranz S; Ghofrani HA Dtsch Med Wochenschr; 2016 Oct; 141(S 01):S33-S41. PubMed ID: 27760448 [TBL] [Abstract][Full Text] [Related]
19. Gender-related differences in pulmonary arterial hypertension targeted drugs administration. Marra AM; Benjamin N; Eichstaedt C; Salzano A; Arcopinto M; Gargani L; D Alto M; Argiento P; Falsetti L; Di Giosia P; Isidori AM; Ferrara F; Bossone E; Cittadini A; Grünig E Pharmacol Res; 2016 Dec; 114():103-109. PubMed ID: 27771466 [TBL] [Abstract][Full Text] [Related]
20. [Treatment of pulmonary arterial hypertension (PAH): recommendations of the Cologne Consensus Conference 2010]. Ghofrani HA; Distler O; Gerhardt F; Gorenflo M; Grünig E; Haefeli WE; Held M; Hoeper MM; Kähler CM; Kaemmerer H; Klose H; Köllner V; Kopp B; Mebus S; Meyer A; Miera O; Pittrow D; Riemekasten G; Rosenkranz S; Schranz D; Voswinckel R; Olschewski H; Dtsch Med Wochenschr; 2010 Oct; 135 Suppl 3():S87-101. PubMed ID: 20862625 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]